Evidence map›Paper›PMID 27875572›Full record

ArticlePloS one2016

Iron-Regulated Phospholipase C Activity Contributes to the Cytolytic Activity and Virulence of Acinetobacter baumannii.

Steven E Fiester, Brock A Arivett, Robert E Schmidt, Amber C Beckett, Tomislav Ticak, Mary V Carrier, Rajarshi Ghosh, Emily J Ohneck, Maeva L Metz, Marlo K Sellin Jeffries and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it, 84 citations in OpenAlex.

  1. Drug-resistantClinical microbiology reviews · 2025
    Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. The intricacies ofFrontiers in microbiology · 2025
    Review
  14. A decade of genomic and phenotypic adaptation of carbapenem-resistantFrontiers in cellular and infection microbiology · 2025
    Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Steven E FiesterDepartment of Microbiology, Miami University, Oxford, Ohio, United States of America.
Brock A ArivettDepartment of Microbiology, Miami University, Oxford, Ohio, United States of America.ORCID http://orcid.org/0000-0002-1291-3814
Robert E SchmidtDepartment of Microbiology, Miami University, Oxford, Ohio, United States of America.
Amber C BeckettDepartment of Microbiology, Miami University, Oxford, Ohio, United States of America.
Tomislav TicakDepartment of Microbiology, Miami University, Oxford, Ohio, United States of America.
Mary V CarrierDepartment of Microbiology, Miami University, Oxford, Ohio, United States of America.
Rajarshi GhoshBiology Department, Middle Tennessee State University, Murfreesboro, Tennessee, United States of America.
Emily J OhneckDepartment of Microbiology, Miami University, Oxford, Ohio, United States of America.
Maeva L MetzDepartment of Microbiology, Miami University, Oxford, Ohio, United States of America.
Marlo K Sellin JeffriesDepartment of Microbiology, Miami University, Oxford, Ohio, United States of America.
Luis A ActisDepartment of Microbiology, Miami University, Oxford, Ohio, United States of America.
Miami University · USMiddle Tennessee State University · US

Funding

Study of iron acquisition in Acinetobacter baumanniiR01AI070174 · NIAID · MIAMI UNIVERSITY OXFORD · PI ACTIS, LUIS A · 2007 to 2011
$1.4M
NIAID NIH HHS R01 AI070174
6 · The paper itself

Abstract

Acinetobacter baumannii is an opportunistic Gram-negative pathogen that causes a wide range of infections including pneumonia, septicemia, necrotizing fasciitis and severe wound and urinary tract infections. Analysis of A. baumannii representative strains grown in Chelex 100-treated medium for hemolytic activity demonstrated that this pathogen is increasingly hemolytic to sheep, human and horse erythrocytes, which interestingly contain increasing amounts of phosphatidylcholine in their membranes. Bioinformatic, genetic and functional analyses of 19 A. baumannii isolates showed that the genomes of each strain contained two phosphatidylcholine-specific phospholipase C (PC-PLC) genes, which were named plc1 and plc2. Accordingly, all of these strains were significantly hemolytic to horse erythrocytes and their culture supernatants tested positive for PC-PLC activity. Further analyses showed that the transcriptional expression of plc1 and plc2 and the production of phospholipase and thus hemolytic activity increased when bacteria were cultured under iron-chelation as compared to iron-rich conditions. Testing of the A. baumannii ATCC 19606T plc1::aph-FRT and plc2::aph isogenic insertion derivatives showed that these mutants had a significantly reduced PC-PLC activity as compared to the parental strain, while testing of plc1::ermAM/plc2::aph demonstrated that this double PC-PLC isogenic mutant expressed significantly reduced cytolytic and hemolytic activity. Interestingly, only plc1 was shown to contribute significantly to A. baumannii virulence using the Galleria mellonella infection model. Taken together, our data demonstrate that both PLC1 and PLC2, which have diverged from a common ancestor, play a concerted role in hemolytic and cytolytic activities; although PLC1 seems to play a more critical role in the virulence of A. baumannii when tested in an invertebrate model. These activities would provide access to intracellular iron stores this pathogen could use during growth in the infected host.

Indexed as

Genome, BacterialA549 CellsAcinetobacter baumanniiAcinetobacter InfectionsAnimalsBacterial ProteinsCattleDisease Models, AnimalHorsesHumansSheepType C PhospholipasesBacterial ProteinsType C Phospholipases

Identifiers

PMID27875572
PMCPMC5119829
OpenAlexW2555544068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.